Personalized oncolytic vaccines for cancer immunotherapy

Project Information

PeptiCrad

Grant agreement ID: 681219

DOI 10.3030/681219

Project closed

EC signature date 6 June 2016

Start date 1 July 2016

End date 30 June 2022

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 1 975 705,00

EU contribution € 1 975 705,00

Coordinated by

HELSINGIN YLIOPISTO
Finland